UPDATE 1-FDA rejects Adamis' emergency drug for severe allergic reaction - Reuters

UPDATE 1-FDA rejects Adamis' emergency drug for severe allergic reaction Reuters (Adds detail, shares). June 6 Adamis Pharmaceuticals Corp said on Monday the U.S. Food and Drug Administration rejected its emergency treatment for acute anaphylaxis, a severe allergic reaction, for the second time. The San Diego-based drug developer's ... Adamis Pharmaceuticals (ADMP) Receives CRL From FDA For Epinephrine Pre-Filled Syringe NDAStreetInsider.com Adamis Pharma's NDA for epinephrine pre-filled syringe rejected a second time by FDA; shares plummet 49% premarketSeeking Alpha FDA Advises Adamis Pharmaceuticals To Expand Human Factors And Reliability To Support Its NDA For Epinephrine ...Benzinga all 8 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNGnkzm_FSbdXC8zHFKlXuI4_Q21mw&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779128179472&ei=-WtVV-G2DcGb3QGts6yABA&url=http://www.reuters.com/article/adamis-pharma-fda-idUSL4N18Y357
via IFTTT